Serum ferritin values between 300 and 800 ng/mL in nontransfusion‐dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable-Reference-Cited by-同舟云学术

Serum ferritin values between 300 and 800 ng/mL in nontransfusion‐dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable

Published:2017-02 Issue:3 Volume:92 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Saliba Antoine N.¹,Musallam Khaled M.²³,Cappellini Maria D.³,Graziadei Giovanna³,Daar Shahina⁴,Viprakasit Vip⁵,Taher Ali T.²^ORCID

Affiliation:

1. Department of MedicineIndiana University School of MedicineIndianapolis, Indiana United States

2. Department of Internal MedicineAmerican University of Beirut Medical CenterBeirut Lebanon

3. Department of Clinical Sciences and CommunityUniversity of Milan, IRCCS Ca’ Granda Foundation Maggiore Policlinico HospitalMilan Italy

4. Department of Hematology, College of Medicine & Health SciencesSultan Qaboos University Oman

5. Department of Pediatrics & Thalassemia Center, Faculty of Medicine Siriraj HospitalMahidol UniversityBangkok Thailand

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.24628

Reference7 articles.

1. Non-transfusion-dependent thalassemias

2. Serum ferritin level and morbidity risk in transfusion-independent patients with -thalassemia intermedia: the ORIENT study

3. Elevated liver iron concentration is a marker of increased morbidity in patients with thalassemia intermedia

4. TaherA VichinskyE MusallamK CappelliniMD ViprakasitV.Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT). In: Weatherall D ed. Thalassaemia International Federation (c) 2013. Nicosia Cyprus: Thalassaemia International Federation 2013.

5. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non‐transfusion‐dependent thalassaemia

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia and iron overload as prognostic markers of outcomes in β-thalassemia;Expert Review of Hematology;2024-07-26

2. Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes;Annals of Hematology;2024-07-19

3. Cellular and animal models for the investigation of β-thalassemia;Blood Cells, Molecules, and Diseases;2024-01

4. How I treat non-transfusion-dependent β-thalassemia;Blood;2023-09-14

5. Current and Future Therapies for β-Thalassaemia: A Review Article;EMJ Hematology;2021-07-27